ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Origin Sciences
Mayo Clinic
Institut Cancerologie de l'Ouest
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Kansas Medical Center
Mayo Clinic
UMC Utrecht
Aarhus University Hospital
Aarhus University Hospital
Jagiellonian University
Tianjin Medical University Second Hospital
AstraZeneca
AstraZeneca
Lanzhou University Second Hospital
National Institutes of Health Clinical Center (CC)
Ferring Pharmaceuticals
Dana-Farber Cancer Institute